Boardminder

    David P. Schenkein, M.D.

    1 board
    Healthcare
    As of 8/31/2026

    0.31

    Boardminder Score™

    Bottom 24% of 4,262 directors

    Lower scoreHigher score

    3.7

    Avg Tenure (yrs)

    Shorter tenure than 73% of directors

    ShorterLonger

    $103K

    Total Compensation

    Lower than 78% of 3,007 one-seat directors

    LowerHigher
    Board Seats Breakdown
    Regeneron Pharmaceuticals, Inc.
    REGN
    F500 #309
    Director
    Healthcare
    Seat Score
    0.31
    Tenure
    3.7 yrs
    Compensation
    $103K
    Excess Return
    -90.3%